Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus

NCT03232398 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT03232398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03232398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus
Lead sponsor
Hadassah Medical Organization
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2018
Completion date
May 31, 2021
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, anticoagulants and bleeding disorders, left ventricular thrombosis